Skip to main content

Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.

Publication ,  Journal Article
Balevic, SJ; Cohen-Wolkowiez, M; Eudy, AM; Green, TP; Schanberg, LE; Clowse, MEB
Published in: J Rheumatol
January 2019

OBJECTIVE: Pregnancies in women with active rheumatic disease often result in poor neonatal outcomes. Hydroxychloroquine (HCQ) reduces disease activity and flares; however, pregnancy causes significant physiologic changes that may alter HCQ levels and lead to therapeutic failure. Therefore, our objective was to evaluate HCQ concentrations during pregnancy and relate levels to outcomes. METHODS: We performed an observational study of pregnant patients with rheumatic disease who were taking HCQ from a single center during 2013-2016. Serum samples were analyzed using high-performance liquid chromatography/mass spectrometry. Primary HCQ exposure was categorized as nontherapeutic (≤ 100 ng/ml) or therapeutic (> 100 ng/ml). Categorical outcomes were analyzed using Fisher's exact test and continuous outcomes using linear regression models, Wilcoxon signed-rank test, Kruskal-Wallis test, t test, and ANOVA. RESULTS: We analyzed 145 samples from 50 patients with rheumatic disease, 56% of whom had systemic lupus erythematosus (SLE). HCQ concentration varied widely among individuals at each trimester. Mean physician's global assessment scores in patients with SLE were significantly higher in those with average drug levels ≤ 100 ng/ml compared to > 100 ng/ml (0.93 vs 0.32, p = 0.01). Of patients with SLE, 83% with average drug levels ≤ 100 ng/ml delivered prematurely (n = 6), compared to only 21% with average levels > 100 ng/ml (n = 19; p = 0.01). HCQ levels were not associated with prematurity or disease activity in non-SLE patients. CONCLUSION: With both high and low HCQ levels associated with preterm birth and disease activity in SLE, further study is necessary to understand HCQ disposition throughout pregnancy and to clarify the relationship between drug levels and outcomes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Rheumatol

DOI

EISSN

1499-2752

Publication Date

January 2019

Volume

46

Issue

1

Start / End Page

57 / 63

Location

Canada

Related Subject Headings

  • Pregnancy Outcome
  • Pregnancy Complications
  • Pregnancy
  • Lupus Erythematosus, Systemic
  • Infant, Newborn
  • Hydroxychloroquine
  • Humans
  • Female
  • Arthritis & Rheumatology
  • Antirheumatic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Balevic, S. J., Cohen-Wolkowiez, M., Eudy, A. M., Green, T. P., Schanberg, L. E., & Clowse, M. E. B. (2019). Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes. J Rheumatol, 46(1), 57–63. https://doi.org/10.3899/jrheum.180158
Balevic, Stephen J., Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, and Megan E. B. Clowse. “Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.J Rheumatol 46, no. 1 (January 2019): 57–63. https://doi.org/10.3899/jrheum.180158.
Balevic SJ, Cohen-Wolkowiez M, Eudy AM, Green TP, Schanberg LE, Clowse MEB. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes. J Rheumatol. 2019 Jan;46(1):57–63.
Balevic, Stephen J., et al. “Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.J Rheumatol, vol. 46, no. 1, Jan. 2019, pp. 57–63. Pubmed, doi:10.3899/jrheum.180158.
Balevic SJ, Cohen-Wolkowiez M, Eudy AM, Green TP, Schanberg LE, Clowse MEB. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes. J Rheumatol. 2019 Jan;46(1):57–63.

Published In

J Rheumatol

DOI

EISSN

1499-2752

Publication Date

January 2019

Volume

46

Issue

1

Start / End Page

57 / 63

Location

Canada

Related Subject Headings

  • Pregnancy Outcome
  • Pregnancy Complications
  • Pregnancy
  • Lupus Erythematosus, Systemic
  • Infant, Newborn
  • Hydroxychloroquine
  • Humans
  • Female
  • Arthritis & Rheumatology
  • Antirheumatic Agents